These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
421 related items for PubMed ID: 30607785
21. Psychometric Properties of EQ-5D-3L and EQ-5D-5L in Cognitively Impaired Patients Living with Dementia. Michalowsky B, Hoffmann W, Xie F. J Alzheimers Dis; 2021; 83(1):77-87. PubMed ID: 34275901 [Abstract] [Full Text] [Related]
22. Comparing the measurement properties of the EQ-5D-5L and the EQ-5D-3L in hypertensive patients living in rural China. Jiang J, Hong Y, Zhang T, Yang Z, Lin T, Liang Z, Lu P, Liu L, Wang B, Xu Y, Luo N. Qual Life Res; 2021 Jul; 30(7):2045-2060. PubMed ID: 33821418 [Abstract] [Full Text] [Related]
23. Evaluating the psychometric properties of the EQ-5D-5L and SF-6D among patients with haemophilia. Xu RH, Dong D, Luo N, Wong EL, Wu Y, Yu S, Yang R, Liu J, Yuan H, Zhang S. Eur J Health Econ; 2021 Jun; 22(4):547-557. PubMed ID: 33761029 [Abstract] [Full Text] [Related]
24. Translation, validity and reliability of the British Sign Language (BSL) version of the EQ-5D-5L. Rogers KD, Pilling M, Davies L, Belk R, Nassimi-Green C, Young A. Qual Life Res; 2016 Jul; 25(7):1825-34. PubMed ID: 26887955 [Abstract] [Full Text] [Related]
25. Psychometric properties comparison between EQ-5D-5L and EQ-5D-3L in the general Thai population. Kangwanrattanakul K, Parmontree P. Qual Life Res; 2020 Dec; 29(12):3407-3417. PubMed ID: 32780315 [Abstract] [Full Text] [Related]
26. The construct validity and responsiveness of the EQ-5D-5L, AQL-5D and a bespoke TTO in acute asthmatics. Crossman-Barnes CJ, Sach T, Wilson A, Barton G. Qual Life Res; 2020 Mar; 29(3):619-627. PubMed ID: 31676971 [Abstract] [Full Text] [Related]
27. Assessing the construct validity and responsiveness of Preference-Based Measures (PBMs) in cataract surgery patients. Breheny K, Hollingworth W, Kandiyali R, Dixon P, Loose A, Craggs P, Grzeda M, Sparrow J. Qual Life Res; 2020 Jul; 29(7):1935-1946. PubMed ID: 32080789 [Abstract] [Full Text] [Related]
28. EQ-5D-Y-3L and EQ-5D-Y-5L proxy report: psychometric performance and agreement with self-report. Fitriana TS, Purba FD, Stolk E, Busschbach JJV. Health Qual Life Outcomes; 2022 Jun 03; 20(1):88. PubMed ID: 35659313 [Abstract] [Full Text] [Related]
29. Psychometric properties of the EQ-5D-5L: a systematic review of the literature. Feng YS, Kohlmann T, Janssen MF, Buchholz I. Qual Life Res; 2021 Mar 03; 30(3):647-673. PubMed ID: 33284428 [Abstract] [Full Text] [Related]
30. The added value of extending the EQ-5D-5L with an itching item for the assessment of health-related quality of life of burn patients: an explorative study. Spronk I, Bonsel GJ, Polinder S, van Baar ME, Janssen MF, Haagsma JA. Burns; 2021 Jun 03; 47(4):873-879. PubMed ID: 33012569 [Abstract] [Full Text] [Related]
31. VEINES-QOL/Sym questionnaire was a reliable and valid disease-specific quality of life measure for deep venous thrombosis. Kahn SR, Lamping DL, Ducruet T, Arsenault L, Miron MJ, Roussin A, Desmarais S, Joyal F, Kassis J, Solymoss S, Desjardins L, Johri M, Shrier I, VETO Study investigators. J Clin Epidemiol; 2006 Oct 03; 59(10):1049-56. PubMed ID: 16980144 [Abstract] [Full Text] [Related]
32. Comparison of the three-level and the five-level versions of the EQ-5D. Christiansen ASJ, Møller MLS, Kronborg C, Haugan KJ, Køber L, Højberg S, Brandes A, Graff C, Diederichsen SZ, Nielsen JB, Krieger D, Holst AG, Svendsen JH. Eur J Health Econ; 2021 Jun 03; 22(4):621-628. PubMed ID: 33733344 [Abstract] [Full Text] [Related]
33. The EQ-5D-5L Improves on the EQ-5D-3L for Health-related Quality-of-life Assessment in Patients Undergoing Total Hip Arthroplasty. Greene ME, Rader KA, Garellick G, Malchau H, Freiberg AA, Rolfson O. Clin Orthop Relat Res; 2015 Nov 03; 473(11):3383-90. PubMed ID: 25488404 [Abstract] [Full Text] [Related]
34. EQ-5D-5L and SF-6D Utility Measures in Symptomatic benign Thyroid Nodules: Acceptability and Psychometric Evaluation. Wong CKH, Lang BHH, Yu HMS, Lam CLK. Patient; 2017 Aug 03; 10(4):447-454. PubMed ID: 28224296 [Abstract] [Full Text] [Related]
35. Assessing the psychometric performance of EQ-5D-5L in dementia: a systematic review. Keetharuth AD, Hussain H, Rowen D, Wailoo A. Health Qual Life Outcomes; 2022 Sep 28; 20(1):139. PubMed ID: 36171595 [Abstract] [Full Text] [Related]
36. Psychometric performance of the Chichewa versions of the EQ-5D-Y-3L and EQ-5D-Y-5L among healthy and sick children and adolescents in Malawi. Ngwira LG, Maheswaran H, Verstraete J, Petrou S, Niessen L, Smith SC. J Patient Rep Outcomes; 2023 Mar 09; 7(1):22. PubMed ID: 36892714 [Abstract] [Full Text] [Related]
37. Comparison of EQ-5D-5L and SPVU-5D for measuring quality of life in patients with venous leg ulcers in an Australian setting. Cheng Q, Kularatna S, Lee XJ, Graves N, Pacella RE. Qual Life Res; 2019 Jul 09; 28(7):1903-1911. PubMed ID: 30778889 [Abstract] [Full Text] [Related]
38. Psychometric assessment of EQ-5D-5L and ReQoL measures in patients with anxiety and depression: construct validity and responsiveness. Franklin M, Enrique A, Palacios J, Richards D. Qual Life Res; 2021 Sep 09; 30(9):2633-2647. PubMed ID: 33835414 [Abstract] [Full Text] [Related]
39. Comparison between the EQ-5D-5L and the EQ-5D-3L in patients with hepatitis B. Jia YX, Cui FQ, Li L, Zhang DL, Zhang GM, Wang FZ, Gong XH, Zheng H, Wu ZH, Miao N, Sun XJ, Zhang L, Lv JJ, Yang F. Qual Life Res; 2014 Oct 09; 23(8):2355-63. PubMed ID: 24627090 [Abstract] [Full Text] [Related]
40. "The validity of the EQ-5D-5L in measuring quality of life benefits of breast reconstruction". Kouwenberg CAE, Kranenburg LW, Visser MS, Busschbach JJ, Mureau MAM. J Plast Reconstr Aesthet Surg; 2019 Jan 09; 72(1):52-61. PubMed ID: 30270015 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]